SCHEMBL26308247

SCHEMBL26308247

CC1(C)CC(C)(C)c2cc(N(c3ccccc3)c3ccc(-c4ccc(N(c5ccc6c(c5)C(C)(C)CC6(C)C)c5ccc6oc7ccccc7c6c5)cc4)cc3)ccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ LMNA P02545 3/20 0.33
▸ TNKS O95271 1/20 0.33
▸ AHR P35869 1/20 0.32
▸ PGR P06401 1/20 0.32
▸ PLA2G2A P14555 1/20 0.32
▸ PLA2G4A P47712 1/20 0.32
▸ RXRA P19793 1/20 0.31
▸ RXRB P28702 1/20 0.31
▸ RXRG P48443 1/20 0.31
▸ HSD11B1 P28845 1/20 0.31
▸ HSP90AA1 P07900 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26303711 0.93 RXRA (0.38) MAPTALDH1A1NPC1SMN1; SMN2KDM4E
SCHEMBL26303497 0.93 RXRA (0.38) MAPTALDH1A1NPC1SMN1; SMN2KDM4E
SCHEMBL26304868 0.93 RXRA (0.38) MAPTALDH1A1NPC1SMN1; SMN2KDM4E
SCHEMBL26304539 0.90 RARA (0.42) MAPTALDH1A1NPC1SMN1; SMN2KDM4E
SCHEMBL26303760 0.90 RARA (0.39) MAPTALDH1A1NPC1SMN1; SMN2KDM4E
SCHEMBL26304251 0.89 RARA (0.42) MAPTALDH1A1NPC1SMN1; SMN2KDM4E
SCHEMBL21788118 0.88 KDM4E (0.32) MAPTALDH1A1NPC1SMN1; SMN2KDM4E
SCHEMBL29331326 0.86 RXRA (0.38) MAPTALDH1A1KDM4EMEN1HPGD
SCHEMBL29331150 0.86 RXRA (0.38) MAPTALDH1A1KDM4EMEN1HPGD
SCHEMBL26303969 0.86 RXRA (0.38) MAPTALDH1A1KDM4EMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12048240-B2 Organic compound, electronic component and electronic apparatus comprising the same SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2024-07-23 — — US disclosed
US-12048240-B2 Organic compound, electronic component and electronic apparatus comprising the same SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2024-07-23 — — US disclosed
WO-2023160121-A1 ORGANIC COMPOUND, ELECTRONIC ELEMENT COMPRISING SAME, AND ELECTRONIC DEVICE 陕西莱特光电材料股份有限公司 2023-08-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12048240-B2 Organic compound, electronic component and electronic apparatus comprising the same PIEZO1, OCIAD1, OSTC MAPT 2677/4885ALDH1A1 366/4885NPC1 1219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback